Gentiopicroside-Induced gastric cancer necroptosis via the HIF-1 signaling pathway: A study involving molecular docking and experimental validation
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311152 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Bo Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Iridoid Glucosides, Signal Transduction, Molecular Docking Simulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Excellent Young Medical Talents Training Program and National nature cultivation fund project of Shanghai Baoshan District Hospital of Integrated Traditional C…, Shanghai Baoshan Science and Technology Commission, National nature cultivation fund project of Shanghai Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine.
Abstract (Originalsprache)
Objectives
Gentiopicroside is an effective treatment for several types of cancer, inducing numerous forms of programmed cancer cell death. However, there are few investigations into the role of necroptosis. By utilizing molecular docking, and experimental validation, this study aims to investigate whether gentiopicroside elicits necroptosis in gastric cancer.
Methods
Using software PyMOL and AutoDock, gentiopicroside was docked with RIPK1, RIPK3, MLKL and HIF-1α proteins. And a cell study was performed based on SGC7901 cells. The necroptosis-related proteins and HIF-1 signaling pathways were explored using western blot (WB) analysis. Finally, an animal study was performed to test the inhibitory effect in vivo.
Results
Docking studies indicated that the docking energies of gentiopicroside to necroptosis-related proteins and necroptosis-characteristic proteins are all below -5 kcal/mol. Additionally, gentiopicroside cells reduce gastric cancer viability and inhibit proliferation. Results from the animal experiments indicated that gentiopicroside inhibits the growth of the gastric cancer xenograft tumor. Western blot and immunohistochemistry (IHC) staining demonstrated that gentiopicroside higher p-receptor-interacting protein kinase 3(p-RIPK3) levels in vitro and in vivo.
Conclusion
The findings of this study revealed that necroptosis is involved in the inhibitory effect of gentiopicroside toward gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Pharmacy, Shanghai Fourth Rehabilitation Hospital, Shanghai, China.
- Department of Pharmacy, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Xiaolu Yang, Beibei Fan
Förderung
- Excellent Young Medical Talents Training Program and National nature cultivation fund project of Shanghai Baoshan District Hospital of Integrated Traditional C…
- Shanghai Baoshan Science and Technology Commission
- National nature cultivation fund project of Shanghai Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine
Zitieren
APA
Xiong, B., Fan, M., Wang, Z., Yang, X., Cao, S., Shen, J., & Fan, B. (2024). Gentiopicroside-Induced gastric cancer necroptosis via the HIF-1 signaling pathway: A study involving molecular docking and experimental validation. PLOS ONE. https://doi.org/10.1371/journal.pone.0311152
Vancouver
Xiong B, Fan M, Wang Z, Yang X, Cao S, Shen J, et al. Gentiopicroside-Induced gastric cancer necroptosis via the HIF-1 signaling pathway: A study involving molecular docking and experimental validation. PLOS ONE. 2024. doi:10.1371/journal.pone.0311152
BibTeX
@article{Xiong2024,
author = {Xiong, Bo and Fan, Mingjie and Wang, Zhihui and Yang, Xiaolu and Cao, Shan and Shen, Jie and Fan, Beibei},
title = {Gentiopicroside-Induced gastric cancer necroptosis via the HIF-1 signaling pathway: A study involving molecular docking and experimental validation},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311152}
}
EUVIMED